{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:25:44Z","timestamp":1790281544699,"version":"4.1.0"},"reference-count":46,"publisher":"American Association for Cancer Research (AACR)","issue":"2","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Malignant pleural mesothelioma (MPM) is an aggressive cancer that occurs more frequently in men, but is associated with longer survival in women. Insight into the survival advantage of female patients may advance the molecular understanding of MPM and identify therapeutic interventions that will improve the prognosis for all MPM patients. In this study, we performed whole-genome sequencing of tumor specimens from 10 MPM patients and matched control samples to identify potential driver mutations underlying MPM. We identified molecular differences associated with gender and histology. Specifically, single-nucleotide variants of BAP1 were observed in 21% of cases, with lower mutation rates observed in sarcomatoid MPM (P &amp;lt; 0.001). Chromosome 22q loss was more frequently associated with the epithelioid than that nonepitheliod histology (P = 0.037), whereas CDKN2A deletions occurred more frequently in nonepithelioid subtypes among men (P = 0.021) and were correlated with shorter overall survival for the entire cohort (P = 0.002) and for men (P = 0.012). Furthermore, women were more likely to harbor TP53 mutations (P = 0.004). Novel mutations were found in genes associated with the integrin-linked kinase pathway, including MYH9 and RHOA. Moreover, expression levels of BAP1, MYH9, and RHOA were significantly higher in nonepithelioid tumors, and were associated with significant reduction in survival of the entire cohort and across gender subgroups. Collectively, our findings indicate that diverse mechanisms highly related to gender and histology appear to drive MPM. Cancer Res; 76(2); 319\u201328. \u00a92015 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-15-0751","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T20:58:22Z","timestamp":1447189102000},"page":"319-328","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Gender-Specific Molecular and Clinical Features Underlie Malignant Pleural Mesothelioma"],"prefix":"10.1158","volume":"76","author":[{"given":"Assunta","family":"De Rienzo","sequence":"first","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Archer","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beow Y.","family":"Yeap","sequence":"additional","affiliation":[{"name":"2Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nhien","family":"Dao","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Sciaranghella","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonios C.","family":"Sideris","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Zheng","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G.","family":"Holman","sequence":"additional","affiliation":[{"name":"3Center for Cancer Computational Biology, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Harvard School of Public Health, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu E.","family":"Wang","sequence":"additional","affiliation":[{"name":"3Center for Cancer Computational Biology, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Harvard School of Public Health, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola S.","family":"Dal Cin","sequence":"additional","affiliation":[{"name":"4Departments of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"4Departments of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Rubio","sequence":"additional","affiliation":[{"name":"3Center for Cancer Computational Biology, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Harvard School of Public Health, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry","family":"Croft","sequence":"additional","affiliation":[{"name":"5Malaysian Genomics Resource Centre, Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Quackenbush","sequence":"additional","affiliation":[{"name":"3Center for Cancer Computational Biology, Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, and Harvard School of Public Health, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Sugarbaker","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiara J.","family":"Munir","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse R.","family":"Battilana","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne E.","family":"Gustafson","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucian R.","family":"Chirieac","sequence":"additional","affiliation":[{"name":"4Departments of Pathology, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Meng","family":"Ching","sequence":"additional","affiliation":[{"name":"5Malaysian Genomics Resource Centre, Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Wong","sequence":"additional","affiliation":[{"name":"5Malaysian Genomics Resource Centre, Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang Chung","family":"Tay","sequence":"additional","affiliation":[{"name":"5Malaysian Genomics Resource Centre, Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Rudd","sequence":"additional","affiliation":[{"name":"5Malaysian Genomics Resource Centre, Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hercus","sequence":"additional","affiliation":[{"name":"5Malaysian Genomics Resource Centre, Kuala Lumpur, Malaysia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sugarbaker","sequence":"additional","affiliation":[{"name":"6Debakey Department of Surgery, Baylor College of Medicine, Houston, Texas."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Richards","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Bueno","sequence":"additional","affiliation":[{"name":"1The Thoracic Surgery Oncology laboratory and the International Mesothelioma Program, Division of Thoracic Surgery and the Lung Center, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,1,14]]},"reference":[{"key":"2022061706175210500_bib1","first-page":"224","article-title":"Asbestos exposure and survival in malignant mesothelioma: a description of 122 consecutive cases at an occupational clinic","volume":"2","author":"Skammeritz","year":"2011","journal-title":"Int J Occup Environ Med"},{"key":"2022061706175210500_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1179\/2049396712Y.0000000016","article-title":"Mesothelioma incidence in 50 states and the District of Columbia, United States, 2003-2008","volume":"19","author":"Henley","year":"2013","journal-title":"Int J Occup Environ Health"},{"key":"2022061706175210500_bib3","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"2022061706175210500_bib4","article-title":"World Health Organization International Agency for Research on Cancer International Association for the Study of Lung Cancer International Academy of Pathology","volume-title":"Pathology and genetics of tumours of the lung, pleura, thymus and heart","author":"Travis","year":"2004"},{"key":"2022061706175210500_bib5","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.athoracsur.2014.04.040","article-title":"Women with malignant pleural mesothelioma have a threefold better survival rate than men","volume":"98","author":"Taioli","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"2022061706175210500_bib6","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.athoracsur.2010.04.110","article-title":"Characteristics of malignant pleural mesothelioma in women","volume":"90","author":"Wolf","year":"2010","journal-title":"Ann Thorac Surg"},{"key":"2022061706175210500_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1126\/science.1204040","article-title":"Exploring the genomes of cancer cells: progress and promise","volume":"331","author":"Stratton","year":"2011","journal-title":"Science"},{"key":"2022061706175210500_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30227","article-title":"The pathogenesis of mesothelioma","volume":"29","author":"Carbone","year":"2002","journal-title":"Semin Oncol"},{"key":"2022061706175210500_bib9","doi-asserted-by":"crossref","first-page":"10854","DOI":"10.1073\/pnas.92.24.10854","article-title":"High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesotheliomas","volume":"92","author":"Bianchi","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706175210500_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib11","first-page":"232","article-title":"The role of key genes and pathways involved in the tumorigenesis of Malignant Mesothelioma","volume":"1845","author":"de Assis","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"2022061706175210500_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ng.912","article-title":"Germline BAP1 mutations predispose to malignant mesothelioma","volume":"43","author":"Testa","year":"2011","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib13","doi-asserted-by":"crossref","first-page":"4485","DOI":"10.1158\/1078-0432.CCR-11-2375","article-title":"New strategies in pleural mesothelioma: BAP1 and NF2 as novel targets for therapeutic development and risk assessment","volume":"18","author":"Ladanyi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2022061706175210500_bib14","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/j.1349-7006.2012.02223.x","article-title":"Frequent inactivation of the BAP1 gene in epithelioid-type malignant mesothelioma","volume":"103","author":"Yoshikawa","year":"2012","journal-title":"Cancer Sci"},{"key":"2022061706175210500_bib15","first-page":"1","article-title":"A microaliquoting technique for precise histological annotation and optimization of cell content in frozen tissue specimens","author":"Richards","year":"2007","journal-title":"Biotech Histochem"},{"key":"2022061706175210500_bib16","doi-asserted-by":"crossref","first-page":"e10612","DOI":"10.1371\/journal.pone.0010612","article-title":"Second generation sequencing of the mesothelioma tumor genome","volume":"5","author":"Bueno","year":"2010","journal-title":"PLoS ONE"},{"key":"2022061706175210500_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1181498","article-title":"Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays","volume":"327","author":"Drmanac","year":"2010","journal-title":"Science"},{"key":"2022061706175210500_bib18","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"2022061706175210500_bib19","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2022061706175210500_bib20","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly"},{"key":"2022061706175210500_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/nbt1239","article-title":"The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements","volume":"24","author":"Shi","year":"2006","journal-title":"Nat Biotechnol"},{"key":"2022061706175210500_bib22","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"2022061706175210500_bib23","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1212\/WNL.0b013e318294b2d6","article-title":"TNFRSF1A polymorphisms rs1800693 and rs4149584 in patients with multiple sclerosis","volume":"80","author":"Comabella","year":"2013","journal-title":"Neurology"},{"key":"2022061706175210500_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"2022061706175210500_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cancergen.2013.04.006","article-title":"Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines","volume":"206","author":"Klorin","year":"2013","journal-title":"Cancer Genet"},{"key":"2022061706175210500_bib26","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/01913120252959227","article-title":"Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases","volume":"26","author":"Roggli","year":"2002","journal-title":"Ultrastruct Pathol"},{"key":"2022061706175210500_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/jso.23699","article-title":"Genomic medicine and targeted therapy for solid tumors","volume":"111","author":"Stevens","year":"2015","journal-title":"J Surg Oncol"},{"key":"2022061706175210500_bib28","first-page":"433","article-title":"Recent advances in the molecular analysis of human malignant mesothelioma","volume":"151","author":"De Rienzo","year":"2000","journal-title":"La Clinica Terapeutica"},{"key":"2022061706175210500_bib29","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.lungcan.2005.03.017","article-title":"Implications of P16\/CDKN2A deletion in pleural mesotheliomas","volume":"49","author":"Ladanyi","year":"2005","journal-title":"Lung Cancer"},{"key":"2022061706175210500_bib30","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1158\/0008-5472.CAN-14-1008","article-title":"Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma","volume":"75","author":"Guo","year":"2015","journal-title":"Cancer Res"},{"key":"2022061706175210500_bib31","doi-asserted-by":"crossref","first-page":"5777","DOI":"10.1158\/1078-0432.CCR-13-0351","article-title":"Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803","volume":"19","author":"Warren","year":"2013","journal-title":"Clin Cancer Res"},{"key":"2022061706175210500_bib32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00439-011-1039-0","article-title":"Sex-specific effect of the TP53 PIN3 polymorphism on cancer risk in a cohort study of TP53 germline mutation carriers","volume":"130","author":"Fang","year":"2011","journal-title":"Hum Genet"},{"key":"2022061706175210500_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","article-title":"Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome: current status of clinical applications and future directions","volume":"17","author":"Sorrell","year":"2013","journal-title":"Mol Diagn Ther"},{"key":"2022061706175210500_bib34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High Incidence of Somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"2022061706175210500_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/gcc.22218","article-title":"Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area","volume":"54","author":"Betti","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"2022061706175210500_bib36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/carcin\/bgu227","article-title":"Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival","volume":"36","author":"Baumann","year":"2014","journal-title":"Carcinogenesis"},{"key":"2022061706175210500_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ejogrb.2014.10.016","article-title":"p16 expression in patients with cervical cancer and its prognostic significance: meta-analysis of published literature","volume":"183","author":"Huang","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2022061706175210500_bib38","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1158\/1078-0432.CCR-04-2661","article-title":"Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review","volume":"11","author":"Singhal","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2022061706175210500_bib39","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00018-013-1439-5","article-title":"Myosin II in mechanotransduction: master and commander of cell migration, morphogenesis, and cancer","volume":"71","author":"Aguilar-Cuenca","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"2022061706175210500_bib40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.1248627","article-title":"Direct in vivo RNAi screen unveils myosin IIa as a tumor suppressor of squamous cell carcinomas","volume":"343","author":"Schramek","year":"2014","journal-title":"Science"},{"key":"2022061706175210500_bib41","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng.2937","article-title":"RHOA mutations in peripheral T cell lymphoma","volume":"46","author":"Cools","year":"2014","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib42","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ng.2984","article-title":"Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma","volume":"46","author":"Kakiuchi","year":"2014","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ng.2873","article-title":"Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas","volume":"46","author":"Palomero","year":"2014","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib44","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/ng.2872","article-title":"Somatic RHOA mutation in angioimmunoblastic T cell lymphoma","volume":"46","author":"Sakata-Yanagimoto","year":"2014","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib45","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/ng.2916","article-title":"A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma","volume":"46","author":"Yoo","year":"2014","journal-title":"Nat Genet"},{"key":"2022061706175210500_bib46","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood-2011-08-372193","article-title":"Megakaryocyte-specific RhoA deficiency causes macrothrombocytopenia and defective platelet activation in hemostasis and thrombosis","volume":"119","author":"Pleines","year":"2012","journal-title":"Blood"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/2\/319\/2741046\/319.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/2\/319\/2741046\/319.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T14:10:10Z","timestamp":1655475010000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/2\/319\/613934\/Gender-Specific-Molecular-and-Clinical-Features"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,14]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,1,14]]},"published-print":{"date-parts":[[2016,1,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-15-0751","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22409303","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409297.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409306","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409285","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409288.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6507746","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409297","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409288","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409300","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6507746.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409285.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409303.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409291","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409291.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409294","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409294.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409300.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22409306.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,14]]}}}